Starting with on-the-ground reporting, Sergio Sismondo set out to understand what happens at every step of the manufacturing chain for a drug, from generating scientific data to designing clinical trials to communicating results. In so doing, he shines a light on what he calls "phantom management": a process that allows for a high degree of control over pharmaceutical science.